Cerebral Arachidonate Cascade in Dementia: Alzheimer's Disease and Vascular Dementia

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|4|1|87-100

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.4, Iss.1, 2006-01, pp. : 87-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Possible Role of Vascular Risk Factors in Alzheimer's Disease and Vascular Dementia

By  

Current Pharmaceutical Design, Vol. 20, Iss. 38, 2014-11 ,pp. : 6007-6013

Bentham Science Publishers

Access to resources Recommend Favorite

Memantine: A Therapeutic Approach in Treating Alzheimer's and Vascular Dementia

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 5, 2005-10 ,pp. : 499-506

Bentham Science Publishers

Access to resources Recommend Favorite

Galantamine in the Treatment of Cognitive Decline in Patients with Vascular Dementia or Alzheimer’s Disease with Cerebrovascular Disease

By Small G.  

CNS Drugs, Vol. 17, Iss. 12, 2003-01 ,pp. : 905-914

Adis International

Access to resources Recommend Favorite

Galantamine is beneficial in both patients with vascular dementia and patients with Alzheimer's disease with cerebrovascular disease

By  

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Efficacy of risperidone in treatment of paranoid symptoms in Alzheimer's disease (A.D.) and vascular dementia (V.D.)

By Wittgens W.   Klieser E.   Trenckmann U.   Beine K.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 351-351

Elsevier

Access to resources Recommend Favorite